↓ Skip to main content

Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled…

Overview of attention for article published in Trials, July 2019
Altmetric Badge

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
62 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial
Published in
Trials, July 2019
DOI 10.1186/s13063-019-3423-3
Pubmed ID
Authors

Juan Carlos Villar, Víctor Mauricio Herrera, Juan Guillermo Pérez Carreño, Eliana Váquiro Herrera, Yeny Zulay Castellanos Domínguez, Skarlet Marcell Vásquez, Zulma Milena Cucunubá, Nilda Graciela Prado, Yolanda Hernández

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 62 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 15%
Student > Ph. D. Student 6 10%
Professor 5 8%
Researcher 5 8%
Student > Master 5 8%
Other 10 16%
Unknown 22 35%
Readers by discipline Count As %
Medicine and Dentistry 13 21%
Biochemistry, Genetics and Molecular Biology 7 11%
Immunology and Microbiology 6 10%
Social Sciences 4 6%
Engineering 3 5%
Other 4 6%
Unknown 25 40%